Separate control of rep and cap expression using mutant and wild-type LoxP sequences and improved packaging system for adeno-associated virus vector production

被引:0
|
作者
Hiroaki Mizukami
Takashi Okada
Yoji Ogasawara
Takashi Matsushita
Masashi Urabe
Akihiro Kume
Keiya Ozawa
机构
[1] Jichi Medical School,Division of Genetic Therapeutics, Center for Molecular Medicine
来源
Molecular Biotechnology | 2004年 / 27卷
关键词
Cre-loxP; mutant loxP; dependovirus; AAV vector; packaging cell line; 293 cells;
D O I
暂无
中图分类号
学科分类号
摘要
Adeno-associated virus (AAV) vectors are a practical choice for gene transfer, and demand for them is increasing. To cope with the necessity in the near future, we have developed a number of approaches to establish packaging cell lines for the production of AAV vectors. In our previous study, a highly regulated expression of large Rep proteins was obtained by using the Cre-loxP switching system. Therefore, in the present study, to regulate Cap expression as well, we developed an inducible expression system for both Rep and Cap proteins by using an additional set of mutant loxP sequences. The mutants possess two base alterations in the spacer region of loxP and recombine specifically with the same counterpart in the presence of Cre. By using two separate plasmids, one with mutant and the other with wild-type loxP sequences, the expression of two different proteins can be induced simultaneously by Cre recombinase. When the LacZencoding plasmid vector was used as a packaging model, a significant packaging titer of 2.1 × 1010 genome copies per 10-cm dish was obtained. These results indicate the importance of controlling Cap expression, in addition to Rep, to achieve an optimum production rate for AAV vectors.
引用
收藏
页码:7 / 14
页数:7
相关论文
共 39 条
  • [21] High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap
    J E Conway
    CMJ ap Rhys
    I Zolotukhin
    S Zolotukhin
    N Muzyczka
    G S Hayward
    B J Byrne
    Gene Therapy, 1999, 6 : 986 - 993
  • [22] Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination
    Wang, XS
    Khuntirat, B
    Qing, KY
    Ponnazhagan, S
    Kube, DM
    Zhou, SZ
    Dwarki, VJ
    Srivastava, A
    JOURNAL OF VIROLOGY, 1998, 72 (07) : 5472 - 5480
  • [23] Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system
    Ueno, T
    Matsumura, H
    Tanaka, K
    Iwasaki, T
    Ueno, I
    Fujinaga, K
    Asada, K
    Kato, I
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (02) : 473 - 478
  • [24] Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system
    Destro, Francesco
    Joseph, John
    Srinivasan, Prasanna
    Kanter, Joshua M.
    Neufeld, Caleb
    Wolfrum, Jacqueline M.
    Barone, Paul W.
    Springs, Stacy L.
    Sinskey, Anthony J.
    Cecchini, Sylvain
    Kotin, Robert M.
    Braatz, Richard D.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 122 - 146
  • [25] Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences
    Nony, P
    Tessier, J
    Chadeuf, G
    Ward, P
    Giraud, A
    Dugast, M
    Linden, RM
    Moullier, P
    Salvetti, A
    JOURNAL OF VIROLOGY, 2001, 75 (20) : 9991 - 9994
  • [26] Construction and Optimization of Novel Adeno-Associated Virus (AAV) Rep Gene Expression Control-System for Stable rAAV-Packaging Insect Cell Line
    Moreno, Fiona
    Caceres, Rodrigo
    Lip, Florence
    Rojas, Hugo
    Kusuma, Angga
    MOLECULAR THERAPY, 2022, 30 (04) : 193 - 193
  • [27] REPLICATION OF ADENO-ASSOCIATED VIRUS-DNA - COMPLEMENTATION OF NATURALLY-OCCURRING REP-MUTANTS BY A WILD-TYPE GENOME OR AN ORI-MUTANT AND CORRECTION OF TERMINAL PALINDROME DELETIONS
    SENAPATHY, P
    TRATSCHIN, JD
    CARTER, BJ
    JOURNAL OF MOLECULAR BIOLOGY, 1984, 179 (01) : 1 - 20
  • [28] Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving Functionality
    Cabanes-Creus, Marti
    Ginn, Samantha L.
    Amaya, Anais K.
    Liao, Sophia H. Y.
    Westhaus, Adrian
    Hallwirth, Claus V.
    Wilmott, Patrick
    Ward, Jason
    Dilworth, Kimberley L.
    Santilli, Giorgia
    Rybicki, Arkadiusz
    Nakai, Hiroyuki
    Thrasher, Adrian J.
    Filip, Adrian C.
    Alexander, Ian E.
    Lisowski, Leszek
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 12 : 71 - 84
  • [29] Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap
    Wustner, JT
    Arnold, S
    Lock, M
    Richardson, JC
    Himes, VB
    Kurtzman, G
    Peluso, RW
    MOLECULAR THERAPY, 2002, 6 (04) : 510 - 518
  • [30] CAP-GT Platform: A Scalable AAV Production System Using Helper Virus-Free Adeno-Associated Viral Vector Packaging/Producer Cell Lines Based in Human Suspension Cells
    Goncalves, Ines do Carmo
    Hein, Kerstin
    Hudjetz, Ben
    Strempel, Nikola
    Riebesehl, Nina
    Kewes, Helmut
    Bauer, Thu
    Bialek, Corinna
    Wissing, Silke
    Faust, Nicole
    MOLECULAR THERAPY, 2019, 27 (04) : 224 - 225